Posted by Michael Wonder on 05 Aug 2016
PBAC post-market reviews of chronic obstructive pulmonary disease medicines and ezetimibe
5 August 2016 - The public submission process is now closed.
Submissions addressing the terms of reference for these post-market reviews have been published on the PBS website.
